MedTrace Logo

Dental and Medical Office iMET to Reduce Teen Tobacco, Alcohol, and Drug Use

NCT00907309 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 121

Last updated 2016-10-07

No results posted yet for this study

Summary

The purpose of the project is to improve adolescent behavioral counseling services in healthcare settings with a new Internet/Intranet-based Motivational Enhancement Therapy (iMET) intervention that targets the use of tobacco, alcohol, and other drugs.

Conditions

  • Use; Tobacco, Harmful
  • Alcohol Abuse
  • Drug Abuse

Interventions

BEHAVIORAL

iMET

Participants will receive the iMET intervention

BEHAVIORAL

iMET/TE

Participants will receive the iMET intervention and also receive TEs (Technological Extenders)

Sponsors & Collaborators

  • Cambridge Health Alliance

    collaborator OTHER

  • Tufts Medical Center

    collaborator OTHER

  • Harvard School of Dental Medicine

    collaborator OTHER

  • Fallon Clinic

    collaborator INDUSTRY

  • Boston Children's Hospital

    lead OTHER

Principal Investigators

  • John R. Knight, MD · Boston Children's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2012-09-30
Completion
2012-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00907309 on ClinicalTrials.gov